In spite of existing proof regarding the augmentation of Gal-3 in patients with heart failure and impaired glucose metabolism, the reduction of the left ventricular contractile reserve among patients with heart failure and diabetes mellitus did not independently alter the plasmatic Gal-3 levels. This evidence concerns the gene LGALS3 and heart failure.